Event Type
Disclosure
Voluntary
Variant
8-K
Other Events. On January 28, 2026, PDS Biotechnology Corporation (the “Company”) issued a press release announcing that results of a National Cancer Institute-l
Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release Dated January 28, 2026. 104 Cover Page Interactive Data File (emb